|
Volumn 33, Issue 12, 2001, Pages 2085-2087
|
Three-year experience with 4-site intradermal booster vaccination with rabies vaccine for postexposure prophylaxis
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
RABIES IMMUNOGLOBULIN;
RABIES VACCINE;
ADULT;
ANTIBODY TITER;
ARTICLE;
CELL CULTURE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
DRUG COST;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RABIES;
WORLD HEALTH ORGANIZATION;
ADOLESCENT;
ADULT;
CHEMOPREVENTION;
HUMANS;
IMMUNIZATION, SECONDARY;
INCIDENCE;
INJECTIONS, INTRADERMAL;
INJECTIONS, INTRAMUSCULAR;
RABIES;
RABIES VACCINES;
THAILAND;
WORLD HEALTH ORGANIZATION;
|
EID: 0035893118
PISSN: 10584838
EISSN: None
Source Type: Journal
DOI: 10.1086/338155 Document Type: Article |
Times cited : (12)
|
References (10)
|